Literature DB >> 29851884

Diagnosis and Management of Anxiety Disorders.

Peter Giacobbe, Alastair Flint.   

Abstract

PURPOSE OF REVIEW: This article provides a synopsis of the current understanding of the pathophysiology of anxiety disorders, the biological and environmental risk factors that contribute to their development and maintenance, a review of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria, and a practical approach to the treatment of anxiety disorders in adults. RECENT
FINDINGS: Despite the ubiquity of anxiety, the evidence is that most individuals with an anxiety disorder are not identified and do not receive guideline-level care. In part, this may be because of the manifold clinical presentations of anxiety disorders and clinicians' lack of confidence in accurately diagnosing and treating these conditions, especially in nonpsychiatric settings. Anxiety disorders represent the complex interplay between biological, psychological, temperamental, and environmental factors. Converging lines of evidence point to dysfunction in regulating activity in the "threat circuit" in the brain as a putative common pathophysiology underlying anxiety disorders. Evidence-based treatments for anxiety disorders, such as cognitive-behavioral therapy and antidepressant medications, have been shown to regulate activity in this circuit, which consists of reciprocal connections between the dorsomedial prefrontal cortex, insula, and amygdala.
SUMMARY: Anxiety disorders are the most common class of emotional disorders and a leading cause of disability worldwide. A variety of effective treatment strategies are available, which may exert their therapeutic benefits from top-down or bottom-up modulation of the dysfunctional brain activity associated with anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29851884     DOI: 10.1212/CON.0000000000000607

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  9 in total

1.  Pre-Procedural Anxiety and Associated Factors Among Women Seeking for Cervical Cancer Screening Services in Shenzhen, China: Does Past Screening Experience Matter?

Authors:  Wei Lin; Weikang Huang; Chaofan Mei; Chuyan Zhong; Leilei Zhu; Peiyi Liu; Shixin Yuan; Zhihua Liu; Yueyun Wang
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

Review 2.  Inhalation Aromatherapy via Brain-Targeted Nasal Delivery: Natural Volatiles or Essential Oils on Mood Disorders.

Authors:  Jieqiong Cui; Meng Li; Yuanyuan Wei; Huayan Li; Xiying He; Qi Yang; Zhengkun Li; Jinfeng Duan; Zhao Wu; Qian Chen; Bojun Chen; Gang Li; Xi Ming; Lei Xiong; Dongdong Qin
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

Review 3.  Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders.

Authors:  Eunsoo Won; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

4.  Jie-Yu-He-Huan Capsule Ameliorates Anxiety-Like Behaviours in Rats Exposed to Chronic Restraint Stress via the cAMP/PKA/CREB/BDNF Signalling Pathway.

Authors:  Xiwen Geng; Hongyun Wu; Zifa Li; Chuanfen Li; Dan Chen; Jiancheng Zong; Zimin Liu; Sheng Wei; Wei Peng
Journal:  Oxid Med Cell Longev       Date:  2021-10-04       Impact factor: 6.543

5.  Association between physical hazardous agent exposure and mental health in the Korean working population: the 5th Korean Working Conditions Survey.

Authors:  Daeil Kwon; Kyeongmin Kwak; Kiook Baek; Youngchan Chi; Sewhan Na; Jong-Tae Park
Journal:  Ann Occup Environ Med       Date:  2021-11-08

Review 6.  A Review of Ocular Complications Associated with Medications Used for Anxiety, Depression, and Stress.

Authors:  Paul A Constable; Dalia Al-Dasooqi; Rhiannon Bruce; Mallika Prem-Senthil
Journal:  Clin Optom (Auckl)       Date:  2022-02-24

Review 7.  Medicinal Cannabis and Central Nervous System Disorders.

Authors:  Yuma T Ortiz; Lance R McMahon; Jenny L Wilkerson
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

Review 8.  The Development and Impact of Anxiety With Migraines: A Narrative Review.

Authors:  Rajeswar Kumar; Saba Asif; Anoushka Bali; Ashujot Kaur Dang; Daniel A Gonzalez
Journal:  Cureus       Date:  2022-06-29

9.  Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico.

Authors:  Flor Cristina Ortiz Rios; Itzel Guadalupe Dávila Ruiz; Elisa Sacal Dumani
Journal:  Drugs Context       Date:  2022-09-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.